PDK4 and glioblastoma: PDK4 was shown to be abundant in patient glioblastoma compared to normal tissue, and indirectly reducing its expression through shRNA targeting the RelA subunit of NF-kB resulted in reduced growth of xenografts in nude mice (Kim et al. 2015).